Recursion Pharmaceuticals, Inc. RXRX Loss Contingency Accrual
Loss Contingency Accrual at other companies
Other financials
Where this comes from
Reported directly by Recursion Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LossContingencyAccrualAtCarryingValue.
The official record: Recursion Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Recursion Pharmaceuticals, Inc.'s loss contingency accrual.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Recursion Pharmaceuticals, Inc.'s loss contingency accrual?
- Recursion Pharmaceuticals, Inc. (RXRX) reported loss contingency accrual of $0 in Q1 2026.